Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases

Ashique, Sumel, De Rubis, Gabriele, Sirohi, Ekta, Mishra, Neeraj, Rihan, Mohd, Garg, Ashish, Reyes, Ruby-Jean, Manandhar, Bikash, Bhatt, Shvetank, Jha, Niraj Kumar, Singh, Thakur Gurjeet, Gupta, Gaurav, Singh, Sachin Kumar, Chellappan, Dinesh Kumar, Paudel, Keshav Raj, Hansbro, Philip M., Oliver, Brian G., Dua, Kamal · 2022 · Chemico-Biological Interactions

Abstract

The human microbiota is fundamental to correct immune system development and balance. Dysbiosis, or microbial content alteration in the gut and respiratory tract, is associated with immune system dysfunction and lung disease development. The microbiota's influence on human health and disease is exerted through the abundance of metabolites produced by resident microorganisms, where short-chain fatty acids (SCFAs) represent the fundamental class. SCFAs are mainly produced by the gut microbiota through anaerobic fermentation of dietary fibers, and are known to influence the homeostasis, susceptibility to and outcome of many lung diseases. This article explores the microbial species found in healthy human gastrointestinal and respiratory tracts. We investigate factors contributing to dysbiosis in lung illness, and the gut-lung axis and its association with lung diseases, with a particular focus on the functions and mechanistic roles of SCFAs in these processes. The key focus of this review is a discussion of the main metabolites of the intestinal microbiota that contribute to host-pathogen interactions: SCFAs, which are formed by anaerobic fermentation. These metabolites include propionate, acetate, and butyrate, and are crucial for the preservation of immune homeostasis. Evidence suggests that SCFAs prevent infections by directly affecting host immune signaling. This review covers the various and intricate ways through which SCFAs affect the immune system's response to infections, with a focus on pulmonary diseases including chronic obstructive pulmonary diseases, asthma, lung cystic fibrosis, and tuberculosis. The findings reviewed suggest that the immunological state of the lung may be indirectly influenced by elements produced by the gut microbiota. SCFAs represent valuable potential therapeutic candidates in this context.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cbi.2022.110231

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Metadata

Authors
Ashique, S., De Rubis, G., Sirohi, E., Mishra, N., Rihan, M., Garg, A., Reyes, R.-J., Manandhar, B., Bhatt, S., Jha, N. K., Singh, T. G., Gupta, G., Singh, S. K., Chellappan, D. K., Paudel, K. R., Hansbro, P. M., Oliver, B. G., & Dua, K.
Venue
Chemico-Biological Interactions
Publisher
Elsevier BV
Published
2022-12
Volume
368
Pages
110231
ISSN
0009-2797 (ISSN-L)
OpenAlex
W4307125854
Cited by
161
References
42
FWCI
8.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. https://app.cochat.ai/papers/10.1016/j.cbi.2022.110231
The paper
Ashique, S., De Rubis, G., Sirohi, E., Mishra, N., Rihan, M., Garg, A., Reyes, R.-J., Manandhar, B., Bhatt, S., Jha, N. K., Singh, T. G., Gupta, G., Singh, S. K., Chellappan, D. K., Paudel, K. R., Hansbro, P. M., Oliver, B. G., & Dua, K. (2022). Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Chemico-Biological Interactions. https://doi.org/10.1016/j.cbi.2022.110231

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.